NCT00180674View on ClinicalTrials.gov

Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

October 31, 2006

Conditions
Liver Fibrosis
Interventions
DRUG

Warfarin

Trial Locations (1)

W2 1NY

St Mary's Hospital NHS Trust, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT00180674 - Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection | Biotech Hunter | Biotech Hunter